In phase 1 it worked with 44% of patients it seems, it's multisite, it could be worth trying for our warrior with mCRPC (metastatic castrate resistant prostate cancer)
Phase 2 trial recruiting: revert horm... - Advanced Prostate...
Phase 2 trial recruiting: revert hormone resistance with apalutamide and ENV105
Written by
Maxone73
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
promising against soft tissue and bone metastasis: AMG 509
2-1-immune-therapy-in-patients-with-metastatic-castration-resistant-prostate-cancer-mcrpc-interim-re
Veru Reports Positive Clinical Results from VERU-111 Phase 1b/2 Trial in Men with Metastatic Castration-Resistant Prostate Cancer, Advancing
-in-men-with-metastatic-castration-resistant-prostate-cancer-advancing-to-pivotal-phase-3-clinical-p
177Lu-PSMA-617 versus docetaxel in chemotherapy-naïve mCRPC: a randomized, controlled, phase 2 non inferiority trial.
rapy-naive-metastatic-castration-resistant-prostate-cancer-a-randomized-controlled-phase-2-non-infer
Dr Slovin from MSKCC discusses treatments for advanced prostate cancer
approaches to Castration Resistant Prostate Cancer, for patients who need to know...
FT-7075, New Phase 1 Clinical Trial
PSCA phase one trial 
VISION trial results of Lu-177-PSMA-617
PTEN gene & hormone resistant 
